Postmenopausal osteoporosis
MONDO:0008159Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
Also known as: bone mineral density quantitative trait locus, osteoporosis, postmenopausal
51 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Can a biosimilar match prolia in strengthening bones?
Disease control CompletedThis trial tests whether an experimental biosimilar called 9MW0311 works as well as the established drug Prolia (both containing denosumab) in postmenopausal women with osteoporosis who are at high risk for fractures. Participants receive either 9MW0311 or Prolia as an injection …
Phase: PHASE3 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Bone drugs may double as liver fat fighters — a trial puts them to the test
Disease control CompletedThis trial investigates whether two common osteoporosis medications, denosumab and alendronate, can reduce liver fat and scarring in postmenopausal women who also have nonalcoholic fatty liver disease (NAFLD). The study will compare changes in liver fat and stiffness over 12 mont…
Phase: PHASE4 • Sponsor: Aristotle University Of Thessaloniki • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could common statins be a surprise weapon against brittle bones?
Disease control CompletedThis study looks at whether adding a statin (atorvastatin or rosuvastatin) to standard osteoporosis treatment can improve bone density in postmenopausal women. Participants are women aged 55 and older with osteoporosis who also have high cholesterol. The trial compares standard t…
Phase: NA • Sponsor: Alkufa university\\collage of pharmacy • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Exercise may cut fall risk in osteoporosis
Disease control CompletedThis pilot trial tests whether a supervised progressive strength and balance exercise program can reduce falls in postmenopausal women aged 60 to 80 with osteoporosis. Participants are randomly assigned to either the supervised program or a standard home-based exercise routine an…
Phase: NA • Sponsor: Instituto Nacional de Rehabilitacion • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Gut health may boost bone density: probiotic study shows promise
Disease control CompletedThis study tested whether taking daily probiotics (Lactobacillus plantarum and Lactobacillus paracasei) for 12 months could improve bone density in postmenopausal women with low bone mass. 170 women participated, taking either the probiotic or a placebo. The goal was to see if th…
Phase: NA • Sponsor: Nordic Biotic Sp. z o.o. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New osteoporosis drug shows promise in Head-to-Head trial
Disease control CompletedThis phase 3 trial tested a new biosimilar drug called ENZ215 (a form of denosumab) against the established drug Prolia in 504 postmenopausal women with osteoporosis. The goal was to see if ENZ215 works as well as Prolia in improving bone density and reducing bone breakdown marke…
Phase: PHASE3 • Sponsor: Enzene Biosciences Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New combo therapy may boost bone strength in older women
Disease control CompletedThis study looked at whether adding eldecalcitol (a vitamin D-like drug) to denosumab (a bone-strengthening shot) works better than denosumab with regular vitamin D for postmenopausal women with weak bones (osteoporosis). About 100 women took part for 12 months. The main goal was…
Phase: PHASE4 • Sponsor: Xi'an Honghui Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New osteoporosis drug safety checked in indian women
Disease control CompletedThis study tested the safety of romosozumab (Evenity) in 100 postmenopausal women in India who have osteoporosis and a high risk of bone fractures. Researchers tracked side effects, serious events, and changes in lab tests and vital signs. They also measured bone density changes …
Phase: PHASE4 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New osteoporosis drug could offer cheaper alternative to prolia
Disease control CompletedThis phase 3 trial tested whether a biosimilar called Bmab 1000 works as well as the established drug Prolia® for treating osteoporosis in postmenopausal women. 479 women aged 55-79 with osteoporosis received either Bmab 1000 or Prolia® as an injection every 6 months. The study m…
Phase: PHASE3 • Sponsor: Biocon Biologics UK Ltd • Aim: Disease control
Last updated Jun 26, 2026 15:15 UTC
-
Red wine compound tested to keep bones strong after menopause
Prevention CompletedThis study looked at whether taking resveratrol (a natural compound found in grapes and red wine) every day could help prevent bone loss in postmenopausal women with low bone mass. 52 women who were 1 to 10 years past menopause took part. Researchers measured bone health through …
Phase: NA • Sponsor: University of Delaware • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
Heart drug may shield bones after menopause
Prevention CompletedThis study tested whether atenolol, a widely used beta blocker for heart conditions, can prevent bone loss in postmenopausal women. 420 healthy women aged 50-75 took either atenolol or a placebo daily for a period. The main goal was to see if the drug slowed bone density loss in …
Phase: PHASE2 • Sponsor: Sundeep Khosla, M.D. • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Probiotic shows promise in preventing menopause bone loss
Prevention CompletedThis study tested whether taking a probiotic called Lactobacillus acidophilus can help prevent bone loss and osteoporosis in women after menopause. 90 women aged 45-70 with a BMI between 27 and 35 took either the probiotic or a placebo. Researchers measured calcium levels and bon…
Phase: NA • Sponsor: Poznan University of Life Sciences • Aim: Prevention
Last updated Jun 27, 2026 08:09 UTC
-
Blood test could replace bone scans for osteoporosis monitoring
Knowledge-focused CompletedThis study looks at whether blood tests called bone turnover markers can quickly show if osteoporosis drugs are working in postmenopausal women. Forty women will receive either bone-strengthening or bone-building medications for six months. The goal is to see if these blood tests…
Phase: NA • Sponsor: Khyber Medical University Peshawar • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Gum disease and osteoporosis: hidden link in older women?
Knowledge-focused CompletedThis study examined 80 postmenopausal women to see if there is a connection between gum (periodontal) disease and osteoporosis. Researchers measured two substances in blood and gum fluid called sclerostin and TNF-α, which may help explain how these conditions affect each other. T…
Sponsor: Recep Tayyip Erdogan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Osteoporosis drug may slow jaw healing after tooth removal
Knowledge-focused CompletedThis study looked at 66 postmenopausal women with osteoporosis who were either taking alendronate (a common bone-strengthening drug) or not. Researchers measured how well the jawbone healed after a tooth extraction using X-rays taken right after, then at 30 and 90 days. The goal …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:05 UTC